Immune reconstitution after autologous peripheral blood progenitor cell transplantation: Effect of interleukin-15 on T-cell survival and effector functions

Experimental Hematology

Volumn 29, Issue 12, 2001, Pages 1503-1516

  Rutella, Sergio ^a   Pierelli, Luca ^a   Bonanno, Giuseppina ^a   Mariotti, Andrea ^a   Sica, Simona ^a   Sorà, Federica ^a   Chiusolo, Patrizia ^a   Scambia, Giovanni ^a   Rumi, Carlo ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 15;

ADULT; APOPTOSIS; ARTICLE; AUTOTRANSPLANTATION; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA; LYMPHOMA; MALE; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ACTINS; ADULT; ANTIGENS, CD; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL SURVIVAL; CYTOKINES; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-15; INTERLEUKIN-2; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS;

EID: 18244381053     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00747-0     Document Type: Article

References (58)

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome
3. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA Leukemia Cooperative Group)
4. + PB progenitors are myeloperoxidase-negative and non cycling irrespective of CD33 or CD13 coexpression
5. + cells
6. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow
7. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults
8. Peripheral blood T cells generated after allogeneic bone marrow transplantation; lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T cell profiles
9. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation
10. Constraints on CD4 recovery postchemotherapy in adults; thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells
11. Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome; correlation of accelerated cell death and attenuated bcl-2 expression
12. + T-cell apoptosis following stem cell transplantation
13. + hematopoietic progenitors
14. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
15. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
16. + cells; analysis of predictive factors and comparison with unselected progenitor transplants
17. Infectious complications after CD34-selected autologous peripheral blood stem cell transplantation
18. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell trans-plantation
19. Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission
20. Interleukin-15; biology and relevance to human disease
21. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals
22. - T cells of human immunodeficiency virus-infected individuals; effects of interleukin-15 and comparison with interleukin-2
23. Biology of the interleukin-2 receptor
24. Interleukin-2 and its receptors; recent advances and new immunological functions
25. + T cell responsiveness to antigen
26. Human monocytes constitutively express membrane-bound, biologically active, and interferon-γ-upregulated interleukin-15
27. S) gene expression
28. Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness
29. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells; a novel mechanism for the antitumor effects of type I IFNs
30. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression
31. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
32. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with Bcl-2 up-regulation, cortical/mature immunophenotype and better early cytoreduction of childhood T cell acute lymphoblastic leukemia
33. High resolution cell division tracking demonstrates the Flt3-ligand-dependence of human marrow CD34+CD38- cell production in vitro
34. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
35. + human blood dendritic cells for active tumor immunotherapy
36. Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content and in vitro BrdUrd incorporation into normal and malignant hematopoietic cells
37. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets; correlation with Bcl-2 expression and consequences for AIDS pathogenesis
38. T cell regeneration; all repertoires are not created equal
39. Cytokine receptor signaling pathways
40. Tyrosine phosphorylation and activation of STAT5, STAT3 and Janus kinases by interleukins 2 and 15
41. Regulation of cell growth by IL-2; role of STAT5 in protection from apoptosis but not in cell cycle progression
42. Uncoupling IL-2 signals that regulate T cell proliferation, survival and Fas-mediated activation-induced cell death
43. Differences in biodistribution, pharmacokinetics and tumor targeting between interleukins 2 and 15
44. IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice
45. Interleukin-15 protects from lethal apoptosis in vivo
46. + T cells is due to defective signaling through the common γ-chain of the IL-2 receptor
47. + T cells enables preservation of a naive repertoire
48. Interleukin-4 (IL-4) or IL-7 prevents the death of resting T cells; Stat6 is probably not required for the effect of IL-4
49. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH
50. The role of the common cytokine receptor γ-chain in regulating IL-2-dependent, activation-induced CD8 T cell death
51. The common cytokine receptor γ chain plays an essential role in regulating lymphoid homeostasis
52. Interleukin-15 redirects the outcome of a tolerizing T-cell stimulus from apoptosis to anergy
53. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes; implications for immunotherapy
54. The pleiotropic functions of interleukin 15; not so interleukin 2-like after all
55. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin-15-deficient mice
56. IL-15 and IL-2; a matter of life and death for T cells in vivo
57. Interleukin-15 as an activator of natural killer cell-mediated antiviral response